Defitelio (defibrotide) – Updated contraindications for use
13/06/2022
Medicines for human use
Direct healthcare professional communication (DHPC)
Defitelio (defibrotide): Do not use for prophylaxis of veno-occlusive disease (VOD) after post-hematopoietic stem-cell transplantation (HSCT)